Federal Circuit Affirms PTAB’s IPR Ruling Against Medtronic Over Catheter Patents
WASHINGTON, D.C. — Affirming an inter partes review (IPR) ruling by the Patent Trial and Appeal Board (PTAB), a Federal Circuit U.S. Court of Appeals panel majority found that Medtronic Inc....To view the full article, register now.
Already a subscriber? Click here to view full article